Lifeboat Foundation

FRIDAY, July 1, 2016 (HealthDay News) — Electrical pulses to the brain may help restore vision in some partially blind patients, German researchers report.

Glaucoma and other types of damage to the eye’s optic nerve typically cause permanent damage. But, the new technique appears to kick-start the brain’s visual control centers, the researchers explained.

A 10-day treatment regimen — entailing upwards of nearly an hour a day of electrical pulses aimed directly into the eye — improved vision among patients who were losing their sight, the researchers said.

Continue reading “Could ‘Zaps’ to the Brain Help Fight Glaucoma?” »

Games to help fight obesity?

Innovative research uses technology to help people with a sweet-tooth lose weight. Researchers believe they can train the brain to better resist temptation and warn people of an unhealthy urge before the temptation occurs.

Specifically, Drexel University psychologists have created a computer game aimed at improving users’ inhibitory control. Additionally, the investigators are also rolling out a mobile app that used in conjunction with the Weight Watchers app, will alert users on unhealthy urges before they strike.

Continue reading “New Gaming Software Hopes to Train Brain to Resist Sweets” »

One of the biggest challenges in treating brain cancer has been getting drugs to cross the blood-brain barrier and attack tumours where they’re needed.

But scientists say they’ve now developed a truly soluble liquid aspirin that can make its way into the brain, and, in the lab at least, kill cancerous glioblastoma cells without harming healthy brain tissue.

The research hasn’t been published in a peer-reviewed journal as yet, so we need to take it with a big pinch of salt for now. But scientists from the Brain Tumour Research Centre at the University of Portsmouth in the UK just presented it at the Brain Tumours 2016 conference in Poland.

Continue reading “Scientists say they’ve developed aspirin that crosses the blood-brain barrier” »

Q-Dot demand in Healthcare is predicted to be high.

http://embedded-computing.com/news/rising-quantum-dots-market/#

Quantum Dots Market is driven by increasing demand for energy efficient displays and lighting solutions, North America accounted for largest quantum dots market share, use of quantum dots in solar cells and VLSI design is expected to open new possibilities for quantum dots market.

Quantum dots are semiconducting nanoparticles that range from 1nm to 10nm diameter in size and demonstrate quantum mechanical properties. The peculiarity of quantum dots is that they have ability to unite their semiconductor properties with those of nanomaterials. In addition, tunable nanocrystal size and superior optical properties have made quantum dots attractive semiconducting material for variety of applications in the field of healthcare, optoelectronics, solar energy, and security among others.

Its painful to bear views that make many think I’m an imbicile and dislike me. So please, if anybody has a rational argument why any of this is wrong, I beg to be enlightened. I’ve set up a diagram for the purpose that will support you to add your criticism exactly where it is pertinent. https://tssciencecollaboration.com/graphtree/Are%20Vaccines%20Safe/406/4083

(1) The National Academy’s Reviews Of Vaccine Safety
The Institute of Medicine of the National Academies has provided several multi-hundred page surveys studying the safety of vaccines, but rather than reassuring, these itemize some iatrogenic conditions being caused, and pronounce the scientific literature inadequate to say whether most others are. The 2011 Institute of Medicine (IOM) Review[1] looked at 146 vaccine-condition pairs for causality, reporting:

• 14 for which the evidence is said to convincingly support causality, the vaccine is causing the condition.
• 4 where the evidence is said to favor acceptance.
• 5 where the evidence is said to favor rejection, including MMR causing autism.
• 123 where the evidence is said insufficient to evaluate.

The 2003 IOM Review on multiple vaccines said[2]:
“The committee was unable to address the concern that repeated exposure of a susceptible child to multiple immunizations over the developmental period may also produce atypical or non-specific immune or nervous system injury that could lead to severe disability or death (Fisher, 2001). There are no epidemiological studies that address this.”
and:
“the committee concludes that the epidemiological and clinical evidence is inadequate to accept or reject a causal relationship between multiple immunization and an increased risk of allergic disease, particularly asthma.”

• None of the IOM Safety Reviews[1][2][3][4] addressed the aluminum (for example whether the aluminum is causing autism), or mentioned contaminants, or discussed animal models although they had concluded as just quoted there is generally no epidemiological or clinical data worth preferring.

(2) The Aluminum.
Alum was added to vaccines back in the 1920’s, with no test of parenteral toxicity until recently[5], because it prods the immature immune system out of its normal operating range.[6] Maybe they figured aluminum is common in the environment, but injection bypasses half a dozen evolved sequential filters that normally keep it out of circulatory flow during development. Vaccines put hundreds of times as much aluminum into infants’ blood as they would otherwise get, and in an unnatural form that is hard for the body to remove.[7][8 (cfsec 4.2)][9]. The published empirical results indicate its highly toxic.

Continue reading “The Top Ten Reasons I Believe Vaccine Safety Is an Epic Mass Delusion” »

Results from quantitative MRI and neuropsychological testing show unprecedented improvements in ten patients with early Alzheimer’s disease (AD) or its precursors following treatment with a programmatic and personalized therapy. Results from an approach dubbed metabolic enhancement for neurodegeneration are now available online in the journal Aging.

The study, which comes jointly from the Buck Institute for Research on Aging and the UCLA Easton Laboratories for Neurodegenerative Disease Research, is the first to objectively show that memory loss in patients can be reversed, and improvement sustained, using a complex, 36-point therapeutic personalized program that involves comprehensive changes in diet, brain stimulation, exercise, optimization of sleep, specific pharmaceuticals and vitamins, and multiple additional steps that affect brain chemistry.

“All of these patients had either well-defined mild cognitive impairment (MCI), subjective cognitive impairment (SCI) or had been diagnosed with AD before beginning the program,” said author Dale Bredesen, MD, a professor at the Buck Institute and professor at the Easton Laboratories for Neurodegenerative Disease Research at UCLA, who noted that patients who had had to discontinue work were able to return to work and those struggling at their jobs were able to improve their performance. “Follow up testing showed some of the patients going from abnormal to normal.”

Continue reading “Pre and post testing show reversal of memory loss from Alzheimer’s disease in 10 patients” »

Elysium Health hasn’t discovered the fountain of youth, but their new supplement—with the backing of some of the world’s foremost authorities on aging—could change how you get older.

It would seem that no one’s immune from the effects imposed by our increasingly sophisticated artificial intelligence and robotics — not even doctors. As research from Indiana University has revealed, a new computer program is doing a better job than doctors when it comes to both diagnosing and treating health conditions — and by a significant margin.

The system, which uses decision making processes similar to the Jeopardy-bot, Watson, was recently given the task of analyzing and predicting the health outcomes of 500 real individuals. After plugging in the relevant data — which mostly had to do with clinical depression and chronic diseases like high blood pressure and diabetes — researchers Kris Hauser and Casey Bennett compared the outcomes to the simulated treatment prescriptions.

A small clinical trial of 10 patients with early Alzheimer’s disease has shown that the memory loss and cognitive impairment caused by the disease can be reversed.

Scientists at the University of California, Los Angeles found a new treatment that could potentially reverse memory loss and cognitive impairment among patients with early Alzheimer’s disease.

In a small clinical trial, 10 individuals underwent a treatment called “metabolic enhancement for neurodegeneration,” or MEND. The treatment is based on 36 different factors, including changes in diet, exercise, and sleeping habits. It also includes the integration of certain drugs, vitamins, and brain stimulation therapy to a patient’s regular routine.

Continue reading “New Alzheimer’s Treatment Could Reverse Memory Loss” »